Cargando…
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
The links between β-amyloid (Aβ) and tau in Alzheimer’s disease are unclear. Cognitively unimpaired persons with signs of Aβ pathology had increased cerebrospinal fluid (CSF) phosphorylated tau (P-tau181 and P-tau217) and total-tau (T-tau), which increased over time, despite no detection of insolubl...
Autores principales: | Mattsson-Carlgren, Niklas, Andersson, Emelie, Janelidze, Shorena, Ossenkoppele, Rik, Insel, Philip, Strandberg, Olof, Zetterberg, Henrik, Rosen, Howard J., Rabinovici, Gil, Chai, Xiyun, Blennow, Kaj, Dage, Jeffrey L., Stomrud, Erik, Smith, Ruben, Palmqvist, Sebastian, Hansson, Oskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159908/ https://www.ncbi.nlm.nih.gov/pubmed/32426454 http://dx.doi.org/10.1126/sciadv.aaz2387 |
Ejemplares similares
-
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
por: Ossenkoppele, Rik, et al.
Publicado: (2021) -
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology
por: Pereira, Joana B., et al.
Publicado: (2022) -
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease
por: Janelidze, Shorena, et al.
Publicado: (2020) -
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals
por: Groot, Colin, et al.
Publicado: (2022) -
Untangling the association of amyloid-β and tau with synaptic and axonal loss
in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2020)